Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M32.0Revenue $M19.0Net Margin (%)-60.7Altman Z-Score-6.7
Enterprise Value $M-6.6EPS $-0.1Operating Margin %-61.5Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.1Pre-tax Margin (%)-60.7Higher ROA y-yY
Price/Book0.610-y EBITDA Growth Rate %-17.6Quick Ratio8.7Cash flow > EarningsY
Price/Sales1.75-y EBITDA Growth Rate %-15.0Current Ratio8.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-20.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-22.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M91.5ROIC % (ttm)-135.5Gross Margin Increase y-yY

Gurus Latest Trades with VICL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VICLJohn Rogers 2015-09-30 Reduce$0.46 - $0.7
($0.61)
$ 0.33-46%Reduce -0.32%7,436,270
VICLJohn Rogers 2015-06-30 Add$0.7 - $1.48
($0.99)
$ 0.33-67%Add 7.21%7,460,515
VICLJohn Rogers 2015-03-31 Add$0.86 - $1.17
($1.02)
$ 0.33-68%Add 7.34%6,958,945
VICLGeorge Soros 2014-09-30 Sold Out $1.12 - $1.31
($1.24)
$ 0.33-73%Sold Out0
VICLGeorge Soros 2014-06-30 Buy $1.12 - $1.35
($1.19)
$ 0.33-72%New holding58,179
VICLJohn Rogers 2013-12-31 Add0.03%$1.015 - $1.49
($1.2)
$ 0.33-73%Add 39.31%7,062,104
VICLJohn Rogers 2013-06-30 Add0.13%$2.93 - $4.22
($3.52)
$ 0.33-91%Add 93.26%5,134,817
VICLJohn Rogers 2013-03-31 Add0.08%$2.91 - $4.26
($3.54)
$ 0.33-91%Add 71.60%2,656,967
VICLJohn Rogers 2012-12-31 Add0.03%$2.74 - $4.32
($3.31)
$ 0.33-90%Add 49.50%1,548,357
VICLJohn Rogers 2012-03-31 Add0.01%$3.02 - $4.28
($3.23)
$ 0.33-90%Add 26.34%877,193
VICLJohn Rogers 2011-06-30 Reduce-0.01%$2.88 - $4.81
($3.75)
$ 0.33-91%Reduce -30.97%577,773
VICLJohn Rogers 2010-09-30 Add0.03%$2.21 - $3.86
($3.2)
$ 0.33-90%Add 548.18%795,728
VICLJohn Rogers 2009-06-30 Buy 0.01%$1.95 - $2.76
($2.28)
$ 0.33-86%New holding137,198
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VICL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VICL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ramos Anthony AlanVP, Chief Accounting Officer 2016-01-25Sell193$0.35-5.71view
SAMANT VIJAY BPresident & CEO 2016-01-12Sell59,737$0.35-5.71view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2016-01-11Sell974$0.36-8.33view
SAMANT VIJAY BPresident & CEO 2016-01-07Sell75,000$0.36-8.33view
Ramos Anthony AlanVP, Chief Accounting Officer 2015-10-23Sell193$0.39-15.38view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2015-10-12Sell974$0.43-23.26view
SAMANT VIJAY BPresident & CEO 2015-10-12Sell4,738$0.41-19.51view
Ramos Anthony AlanVP, Chief Accounting Officer 2015-07-23Sell194$0.62-46.77view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2015-07-13Sell974$0.7-52.86view
SAMANT VIJAY BPresident & CEO 2015-07-13Sell4,737$0.7-52.86view

Quarterly/Annual Reports about VICL:

    News about VICL:

    Articles On GuruFocus.com
    CEOs Sell Vical, PhotoMedex, E.W. Scripps, Smart & Final Stores Jan 18 2016 
    Red Hat (RHT) and Five Below (FIVE) Strong Performance Metrics; Vical (VICL) Targets Multi-billion S Mar 26 2015 
    John Rogers Comments on Vical Feb 26 2014 
    Kids Decide on Dolls or Devices - JAKK, Others 70% Off Sep 17 2013 
    Weekly CFO Buys Highlight: VICL, EXA, UCBA, YORW, MGI Jan 21 2013 
    Vical Inc. Insiders Boost Shares after Company’s NASDAQ Listing Gets Upgrade Jan 17 2013 
    Two Biotech Stocks to Buy, One to Avoid Jan 09 2012 
    Vical Inc. (VICL) CEO Vijay B Samant buys 1,000 Shares Jan 20 2011 
    Vical Inc. Reports Operating Results (10-Q) Aug 06 2010 
    Vical Inc. Reports Operating Results (10-Q) May 07 2010 

    More From Other Websites
    VICAL INC Files SEC form 8-K, Other Events Feb 04 2016
    VICAL INC Financials Jan 29 2016
    CEOs Sell Vical, PhotoMedex, E.W. Scripps, Smart & Final Stores Jan 18 2016
    Vical's VL-2397 Gets Orphan Status for Invasive Aspergillosis Jan 07 2016
    FDA Grants Vical Orphan Drug Designation for VL-2397 for the Treatment of Invasive Aspergillosis Jan 06 2016
    FDA Grants Vical Orphan Drug Designation for VL-2397 for the Treatment of Invasive Aspergillosis Jan 06 2016
    Vical Appoints Dr. Thomas Shenk to Board of Directors Dec 21 2015
    VICAL INC Files SEC form 8-K, Change in Directors or Principal Officers Dec 21 2015
    Vical Appoints Dr. Thomas Shenk to Board of Directors Dec 21 2015
    4 Stocks Under $10 to Trade for Big Breakouts Nov 29 2015
    Hedge Funds Are Selling Vical Incorporated (VICL) Nov 28 2015
    What Do Hedge Funds Think of Enzon Pharmaceuticals, Inc. (ENZN)? Nov 25 2015
    Vical to Present at the Stifel Healthcare Conference 2015 Nov 11 2015
    Vical to Present at the Stifel Healthcare Conference 2015 Nov 11 2015
    4 Stocks Under $10 to Trade for Big Breakouts Nov 04 2015
    VICAL INC Files SEC form 10-Q, Quarterly Report Oct 30 2015
    Vical beats Street 3Q forecasts Oct 29 2015
    Vical beats Street 3Q forecasts Oct 29 2015
    Vical Reports Third Quarter 2015 Financial Results and Progress in Key Development Programs Oct 29 2015
    VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Oct 29 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK